feed,title,long_url,short_url
Benzinga,BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis,https://benzinga.com/general/biotech/22/01/24965095/biomarins-hemophilia-gene-therapy-meets-efficacy-endpoints-at-two-year-analysis,https://j.mp/3Fa0yuL
Benzinga,"Biotech Pluristem, Israel-Based Tnuva Collaborate On Cultured Food Platform",https://benzinga.com/general/biotech/22/01/24964810/biotech-pluristem-israel-based-tnuva-collaborate-on-cultured-food-platform,https://j.mp/3G8rpIW
